Table 2.
Biomarkers | ConcordanceN (%) | DiscordanceN (%) | Total discordanceN (%) | ||
---|---|---|---|---|---|
PL (+) | PL (−) | PL (+) | PL (−) | ||
RL (+) | RL (−) | RL (−) | RL (+) | ||
ER | 27 (40.3%) | 22 (32.8%) | 8 (11.9%) | 10 (14.9%) | 18 (26.9%) |
PR | 11 (16.4%) | 30 (44.8%) | 17 (25.4%) | 9 (13.4%) | 26 (38.8%) |
HER2 | 19 (29.7%) | 33 (49.3%) | 5 (7.5%) | 10 (14.9%) | 15 (22.4%) |
PL: Primary lesions; RL: Recurrent lesions.